Stefanie Colella-Walsh

Stefanie Colella-Walsh Stefanie Colella-Walsh is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. Ms. Colella-Walsh is also a Shareholder in several of Stark & Stark's Litigation Teams. Ms. Colella-Walsh has extensive experience as a trial attorney throughout the state of New Jersey.

Posts by Stefanie Colella-Walsh

Ruling May Open the Door in New Jersey for Otherwise Time-Barred Cases

Posted in Accutane, Defective Drugs

The New Jersey Supreme Court recently reinstated a $25 million jury award for an Alabama man who suffered from severe inflammatory bowel disease after taking Accutane. Accutane is a prescription medication used for the treatment of acne. In June 1995, while living in Alabama, the plaintiff was prescribed Accutane by his dermatologist and took the drug… Continue Reading

Bair Hugger Lawsuit MDL Judge Issues Bellwether Trial Order

Posted in Bair Hugger Lawsuit, Medical Devices

A Multidistrict Litigation (“MDL”) against 3M and Arizant Healthcare, alleging the manufacturers’ Bair Hugger surgical warming blankets were the cause of deadly post-surgical infections, has progressed to the bellwether pretrial stage. The more than 800 cases were recently consolidated in Minnesota under the purview of the Honorable Joan N. Ericksen. Bellwether case selection will begin… Continue Reading

Petition Denied for DePuy MDL Appeal

Posted in DePuy Pinnacle

The 5th District court in Texas recently denied a petition by defendants, Johnson & Johnson and DePuy Orthopedics, Inc., to grant an expedited appeal and to halt the next round of bellwether trials in the Pinnacle multidistrict litigation (MDL), which are currently scheduled to begin in early September 2016. The defendants filed the petition after… Continue Reading

Recalled Zimmer Persona TM Tibia Knee Implant Claims Expected to be on the Rise

Posted in Medical Devices, Zimmer Persona

In 2012, Zimmer introduced its Persona Personalized Knee Replacement System. When components in the system were called into question for loosening, Zimmer issued a recall of more than 11,500 porous coated, uncemented Zimmer Persona Trabecular Metal Tibial Plates, as well as the Zimmer Persona Tibial Articular Surface Provisional (TASP) Shim tool, in March 2015. Zimmer… Continue Reading

Canadian Government Launches Xarelto Investigation

Posted in Defective Drugs, Xarelto

Xarelto (rivaroxaban) is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in July 2011 to prevent strokes in patients who received hip and knee replacements. In November 2011, the approval was expanded to any patients with atrial fibrillation (irregular heartbeat). Xarelto has been widely prescribed, with millions of people… Continue Reading

GlaxoSmithKline Seeks Consolidation of Zofran Lawsuits in Federal Court

Posted in Defective Drugs, Zofran

Zofran (ondansetron), manufactured by GlaxoSmithKline (GSK), is a member of a class of drugs known as 5-HT3 receptor antagonists, which work by blocking the actions of serotonin. Zofran is commonly prescribed for use by pregnant women suffering from morning sickness. Studies show that Zofran use by pregnant women can lead to a heightened risk of… Continue Reading

Xarelto Litigation Continues to Grow

Posted in Defective Drugs, Xarelto

Xarelto (Rivaroxaban) is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in July 2011, to prevent strokes in patients who received hip and knee replacements. In November 2011, the approval was expanded to any patients with atrial fibrillation (irregular heartbeat). Xarelto has been widely prescribed, with millions of people… Continue Reading

Xarelto Cases Consolidated in New Orleans, Louisiana

Posted in Defective Drugs, Xarelto

The United States Judicial Panel on Multi-District Litigation (MDL) recently convened to determine whether the cases, known as IN RE: XARELTO (RIVAROXABAN) PRODUCTS LIABILITY LITIGATION, should be given MDL treatment. Granting MDL treatment consolidates all federal lawsuits filed across the United States into one centralized district. This consolidation streamlines the pretrial discovery process, allowing the… Continue Reading

Boston Scientific To Pay Millions Following West Virginia Mesh Trial

Posted in Transvaginal Mesh

Trials against vaginal mesh device manufacturer, Boston Scientific Corp. (“Boston Scientific”), continue in West Virginia. Only one week after a jury in Miami’s federal court ordered Boston Scientific to pay $26.7 million to 4 plaintiffs, the company has now been ordered to pay another $18.5 million to an additional 4 plaintiffs. The plaintiffs in the… Continue Reading

Pelvic Mesh Manufacturers Lose Preliminary Objections in Pennsylvania

Posted in Transvaginal Mesh

The litigation against manufacturers of pelvic mesh devices continues to increase nationwide. A pelvic mesh implant is a synthetic material implanted and tied to ligaments or bone to lift and support internal organs. The implants were introduced over a decade ago, and can serve as an alternative to a hysterectomy. Thousands of women, who were… Continue Reading

Boehringer Ingelheim Sanctioned Again in Pradaxa Litigation

Posted in Pradaxa

As we have previously reported, Boehringer Ingelheim, the manufacturer of Pradaxa, has been sanctioned during the course of the federal litigation for destroying relevant documents. In a recent Case Management Order, Judge David R. Herndon, Chief Judge United States District Court, presiding over the litigation, revisited the manufacturer’s misconduct and fixed new sanctions. In the… Continue Reading

Plaintiffs Ask Department of Justice to Investigate Johnson & Johnson’s Destruction of Pelvic Mesh Documents

Posted in Transvaginal Mesh

As we have previously reported, plaintiffs have alleged that employees of Johnson & Johnson’s Ethicon unit, manufacturers of the Gynecare Prolift implant, mishandled documents related to the device. Plaintiffs recently asked the Department of Justice to launch an investigation into Ethicon’s handling of thousands of documents related to the device. The consumer advocacy group, Corporate… Continue Reading

Boehringer Ingelheim Sanctioned $931,000 for Destroying Documents

Posted in Pradaxa

The use of Pradaxa has been linked to serious injury. There are nearly 2,000 cases currently pending in federal court in the Southern District of Illinois. Pradaxa is a blood thinner that was marketed to replace warfarin, a commonly used anticoagulant. Unfortunately, there is no readily-available antidote for the internal bleeding that can sometimes occur in patients treated… Continue Reading

DePuy ASR Lawsuits to Settle

Posted in DePuy ASR

As we have previously reported, DePuy Orthopedics, Inc., was involved in detailed settlement discussions to resolve thousands of lawsuits involving its ASR hip device. The cases, centralized in federal court as part of a multi-district litigation (“MDL”) and centralized in New Jersey state court, may soon resolve for those plaintiffs who underwent revision surgery. The… Continue Reading

Over 150 Cases Added to DePuy Pinnacle Lawsuit

Posted in DePuy ASR, DePuy Pinnacle

As we have previously reported, there are over 10,000 lawsuits pending nationwide against Johnson & Johnson for its metal-on-metal hip replacements, the DePuy Pinnacle and the DePuy ASR. Plaintiffs allege that the metal-on-metal hip replacement devices have a higher-than-normal failure rate. Additionally, some plaintiffs have complained that the device has caused metal poisoning, called metallosis,… Continue Reading

NJ Court Reinstates Bristol-Myers Wrongful Death Suits

Posted in Bristol-Myers Squibb

Recently, Stark & Stark’s Mass Tort team successfully argued for the reinstatement of two dozen previously dismissed wrongful death claims against Bristol-Myers Squibb.  U.S. Magistrate Judge Douglas E. Arpert ruled that federal toxic tort law preempts any limitations period in New Jersey’s Wrongful Death Act. Originally, it had been held that the time that plaintiffs… Continue Reading

C.R. Bard Settles New Jersey Vaginal Mesh Case Prior to Trial

Posted in Transvaginal Mesh

As we have previously reported, the vaginal mesh implant litigation continues to move forward nationwide. A mesh implant is a synthetic material implanted and tied to ligaments or bone to lift and support internal organs. The implants were introduced over a decade ago and serve as an alternative to a hysterectomy. Thousands of women, who… Continue Reading

Byetta and Januvia Lawsuits May Soon Be Consolidated

Posted in Byetta, Januvia/Janumet and Victoza

As we have previously reported, safety concerns regarding incretin mimetics such Byetta, Januvia/Janumet and Victoza, have lead to hundreds of lawsuits being filed across the country. Reports suggest that people taking the medications, Januvia and/or Byetta, for the treatment of Type 2 diabetes may be at an increased risk to develop pancreatitis or pancreatic cancer…. Continue Reading

Johnson & Johnson to Discontinue Pinnacle Metal-on-Metal Hip Implants

Posted in DePuy ASR, DePuy Pinnacle, Medical Devices

Currently, there are more than 10,000 lawsuits pending nationwide against Johnson & Johnson for its metal-on-metal hip replacements, the DePuy Pinnacle and the DePuy ASR. Plaintiffs allege that the metal-on-metal hip replacement devices have a higher-than-normal failure rate. Additionally, some plaintiffs have complained that the device has caused metal poisoning, called metallosis, due to high… Continue Reading

Mirena Litigation Centralized in New Jersey State Court

Posted in Medical Devices, Mirena®

On May 13, 2013, a Notice to the Bar was issued by Judge Glenn A. Grant, Acting Administrator of the Courts, advising that an application had been made, pursuant to Directive #7-09, “Revised Mass Tort Guidelines,” requesting designation of all New Jersey state-court litigation involving Mirena Intrauterine device (IUD) as a multicounty litigation and assignment… Continue Reading

Federal Court Sets Initial Conference in Mirena Federal Lawsuit

Posted in Medical Devices, Mirena®

The Mirena Intrauterine device (IUD) is a hormonal device that is inserted into a woman’s uterus for long-term birth control. A T-shaped plastic frame releases a type of progestin that prevents sperm from reaching or fertilizing an egg. Originally, the device was marketed to prevent pregnancy for up to five years after insertion. However, women… Continue Reading

Stryker ShapeMatch Recall and FDA WarningStryker ShapeMatch Recall and FDA Warning

Posted in Medical Devices

Stryker Corporation has recalled its ShapeMatch Cutting Guides due to manufacturing concerns with the device.   The ShapeMatch is intended to be used as a patient specific surgical instrumentation to assist in the positioning of total knee replacement components and is used to guide the marking of bone before cutting. Stryker has acknowledged that the guides… Continue Reading